NASDAQ:AUPH

Aurinia Stock Dips as Traders Eye Lupkynis Data
····

Aurinia Stock Dips as Traders Eye Lupkynis Data

Aurinia Pharmaceuticals shares fell 0.9% to $15.21 in late morning Nasdaq trading Friday, underperforming the broader biotech sector. Investors focused on Lupkynis sales and the upcoming June 3 shareholder meeting, with no new company news released. The company relies on Lupkynis as its only approved drug and faces competition from GSK’s Benlysta and Genentech’s Gazyva.
May 29, 2026

Stock Market Today

  • Australian Shares Rise 0.9% Amid Inflation Data and Middle East Ceasefire Talks
    May 29, 2026, 12:36 PM EDT. Australian shares rebounded 0.9% on the week as investors digested easing headline inflation, a tentative 60-day US-Iran ceasefire extension, and falling oil prices. The S&P/ASX 200 closed at 8,731.7 points, marking a second consecutive monthly rise of 0.8% in May. Mining and materials stocks led gains on expectations of reopening the Strait of Hormuz, while banks and growth stocks remained volatile amid inflation concerns. Australia's April CPI inflation slowed to 4.2% year-on-year, below forecasts, easing pressure on an immediate Reserve Bank rate hike and boosting risk appetite. Despite softer oil prices, geopolitical risks kept markets cautious, with a mixed impact on energy and travel sectors. The RBA maintains a higher-for-longer interest rate outlook due to persistent trimmed mean inflation at 3.4%.